---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-21-012392"
form_type: "8-K"
ticker: "ZOMDF"
cik: "0001684144"
company_name: "Zomedica Corp."
filed_at: "2021-11-18T23:59:59+00:00"
generated_at: "2026-06-28T07:01:44.625337+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Zomedica discloses 10b5-1 trading plans covering up to 8.06M common shares

## Summary
- Three directors, one executive officer, and other employees adopted Rule 10b5-1 plans for the period Jan 1–Dec 31, 2022.
- Plans cover a maximum of 8,061,842 common shares, including 7,101,842 shares from outstanding stock options.
- Plans were adopted for long-term financial planning, retirement, and diversification; trades are pre-arranged but not guaranteed.

## SEC filing metadata
- accession: 0001654954-21-012392
- form_type: 8-K
- ticker: ZOMDF
- cik: 0001684144
- company_name: Zomedica Corp.
- filed_at: 2021-11-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1684144/000165495421012392/0001654954-21-012392-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1684144/000165495421012392/zom_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-21-012392
- JSON: https://secwatch.observer/filing/0001654954-21-012392.json
- Plain text: https://secwatch.observer/filing/0001654954-21-012392.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.